Research Highlights

Current Research Highlights

Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations

June 11, 2026

In 2025, the Women Informed to Screen Depending on Measures of Risk (WISDOM) study...

Read More
Highlights
Photos of Dr. Yiwey Shieh, a breast cancer ribbon, and a doctor and patient

Grant Aims to Transform Care for Young Cancer Survivors

May 30, 2026

Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute, part of the National Institutes of Health, to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults (AYAs). For these individuals, cancer survival often marks the beginning of lifelong challenges from treatment effects.

Every year, over 80,000 people aged 15 to 39 are diagnosed with cancer. And more than 2...

Read More
Highlights
Image of cancer patient

Air Pollution and the Risk of Second Primary Lung Cancer Among Lung Cancer Survivors

May 21, 2026

Lung cancer is the leading cause of cancer death worldwide. Though advances in early detection and therapeutics have increased the number of long-term lung cancer survivors, these survivors are at high risk of developing second primary lung cancer (SPLC). Survivors diagnosed with SPLC have a sig...

Read More
Highlights
Photos of Dr. Eunji Choi, a lung cancer screening, and air pollution

Performance of a Deep Learning Breast Cancer Risk Model With the Addition of a Polygenic Risk Score

May 14, 2026

Currently, screening mammography recommendations are age-based, but a new risk-based screening paradigm is gaining traction. This approach tailors screening initiation, frequency, and the need for supplemental services, aiming to minimize harm for low-risk women and maximize benefits for...

Read More
Highlights
Photos of a breast cancer ribbon, Dr. Shadi Azam, and Dr. Rulla Tamimi

Barriers to Health Care and Cancer Screening

May 4, 2026

Cancer prevention and screening efforts accounted for 4.75 million deaths averted from 1975 to 2020. Though early detection through routine cancer screening remains one of the most effective strategies for reducing morbidity and mortality associated with common malignant tumors, substantial disparities persist in screening across various...

Read More
Highlights
Photos of a doctor filling out a form, Dr. Kevin Kensler, and Dr. Aaron Gurayah

Follow us on X

Check out our X feed for the latest news.

Population Health Sciences 575 Lexington Avenue | 425 E. 61st Street, 3rd Floor New York, NY Phone: (646) 962-8001